Table 3 Preoperative structural outcome in three groups
Group AS (N = 59) | Group PS (N = 21) | Group API: (N = 22) | |
|---|---|---|---|
Oizumi classification | |||
Grade O | 19 (32.2%) | 6(28.6%) | 3 (13.6%) |
Grade I | 30 (50.8%) | 7 (33.3%) | 8 (36.4%) |
Grade II | 8 (13.6%) | 7 (33.3%) | 4(18.2%) |
Grade III | 2 (3.4%) | 1 (4.8%) | 5 (22.7%) |
Grade IV | 0 (0%) | 0 (0%) | 2 (9.1%) |
Retraction (mm) | 29.1 ± 6.2 | 31.2 ± 10.4 | 37.1 ± 8.7 |
Width (mm) | 34.7 ± 6.0 | 37.2 ± 10.4 | 45.0 + 9.8 |
Muscle atrophy (%) | |||
SSC | 246.5 ± 83.5 | 220.3 ± 67.4 | 252.1 ± 82.4 |
SSP | 76.2 ± 19.8 | 78.9 ± 18.6 | 71.3 ± 16 |
ISP/TM | 220.4 ± 51.9 | 183.4 ± 38.5 | 187.4 ± 54.8 |
Fatty degeneration (%) | |||
SSC | 5.35 ± 8.25 | 3.5 ± 5 20 | 6.0 ± 7.23 |
SSP | 7.84 ± 10.24 | 11.42 ± 10.15 | 12.2 ± 9.7 |
ISP/IM | 3.35 ± 4.92 | 8.52 ± 9.23 | 6.05 ± 5.2 |
Goutallier classification SSC | |||
Stage 0 | 24 (40.7%) | 9 (42.9%) | 6 (27.3%) |
Stage 1 | 26 (44.1%) | 8 (38.1%) | 5 (22.7%) |
Stage 2 | 7 (11.9%) | 4 (19.0%) | 9 (40.9%) |
Stage 3 | 2 (3.4%) | 0 (0%) | 1 (4.5%) |
Stage 4 | 0 (0%) | 0 (0%) | 1 (4.5%) |
Goutallier classification SSP | |||
Stage 0 | 13 (22%) | 2 (9.5%) | 2 (9.0%) |
Stage 1 | 16 (27.1%) | 5 (23.8%) | 5 (22.7%) |
Stage 2 | 21 (35.6%) | 11 (52.4%) | 10 (45.5%) |
Stage 3 | 7 (11.9%) | 2 (9.5%) | 1 (4.5%) |
Stage 4 | 2 (3.4%) | 1 (4.8%) | 4 (18.2%) |
Goutallier classification ISP/TM | |||
Stage 0 | 28 (47.5%) | 5 (22.7%) | 5 (22.7%) |
Stage 1 | 26 (44.1%) | 6 (27.3) | 9 (40.9%) |
Stage 2 | 3 (5.0%) | 7 (31.8%) | 5 (22.7%) |
Stage 3 | 2 (3.4%) | 3 (13.6%) | 1 (4.5%) |
Stage 4 | 0 (0%) | 0 (0%) | 2 (9.0%) |
GFDI | 1.02 ± 0.62 | 1.36 + 0.5 | 1.29 ± 0.5 |